Home
ICON Views
Emerging Markets
Investigators
Contact
SERVICES
THERAPEUTICS
TECHNOLOGY
INVESTORS
NEWS & EVENTS
CAREERS
Biomarkers
ICON provides a full range of laboratory services that are dedicated exclusively to clinical development.
Bioanalytical Laboratories
Biomarkers
Key Technology Platforms
Key Analytical Services
Menu of Biomarker Assays
Global Central Laboratories
Physical/ Chemical Analysis
ICON plc - Clinical Research Organisation (CRO) for Drug Development »
Services »
Laboratories »
Biomarkers »
Key Analytical Services
PRECLINICAL / PHASE I
PHASE II-IIIB
LATE PHASE
LABORATORIES
IMAGING
RESOURCING
Key Analytical Services
Related Information
ICON Biomarkers Overview »
Related News
ICON Strengthens Global Scientific Council with the Appointments of Professor Brendan Buckley and Dr. Nicholas Alp »
ICON Selected by Shire plc’s Specialty Pharmaceuticals division as Global Strategic Partner for Clinical Research and Central Laboratory Services »
ICON PLC and Empire Genomics Partner for the Delivery of Personalised Medicine Services »
ICON Appointment Mario Rocci as President of Early-Phase Division »
More news »
Immunology/Serology
Pharamacogenomics
Biostorage
Viral serology
Autoimmune
Electrophoresis
Immunoglobulins
Cytokines
Growth Factors
Angiogenesis
Extractions
PBMCs
Risk factors
CYP450
HLA typing
PBMC
PK/PD
PGX
Tissue
Cellular Immunology
Infectious Disease
Clinical Chemistry
Immunophenotyping
Intracellular Assays
Cell Signaling
Saturation Assays
Viral PCR
Quantitative, Qualitative
HIV, Hep C
Viral Genotyping
HIV, & Hep C
HIV Resistance
Microbiology
qPCR
General Safety
Bone Markers
Cardiac Markers
Diabetes Markers
Endocrinology
Lipids
Specific Proteins
Hematology
Coagulation
Pathology
General Safety
Cell Morphology
Erythrpoietic Markers
Anticoagulant Monitoring
Factor Assay
Sample handling
Solid Tumor Testing
IHC